List of Excipients in API fosaprepitant dimeglumine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing fosaprepitant dimeglumine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme LLC | EMEND | fosaprepitant dimeglumine | 0006-3061 | ANHYDROUS LACTOSE | |
| Merck Sharp & Dohme LLC | EMEND | fosaprepitant dimeglumine | 0006-3061 | EDETATE DISODIUM | |
| Merck Sharp & Dohme LLC | EMEND | fosaprepitant dimeglumine | 0006-3061 | HYDROCHLORIC ACID | |
| Merck Sharp & Dohme LLC | EMEND | fosaprepitant dimeglumine | 0006-3061 | POLYSORBATE 80 | |
| Merck Sharp & Dohme LLC | EMEND | fosaprepitant dimeglumine | 0006-3061 | SODIUM HYDROXIDE | |
| Merck Sharp & Dohme Corp | EMEND | fosaprepitant dimeglumine | 0006-3884 | ANHYDROUS LACTOSE | |
| Merck Sharp & Dohme Corp | EMEND | fosaprepitant dimeglumine | 0006-3884 | EDETATE DISODIUM | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing fosaprepitant dimeglumine
Detailed excipient profiles for fosaprepitant dimeglumine
Excipient focus: ANHYDROUS LACTOSE
fosaprepitant dimeglumine drug variants containing ANHYDROUS LACTOSE
fosaprepitant dimeglumine drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BETADEX SULFOBUTYL ETHER SODIUM
fosaprepitant dimeglumine drug variants containing BETADEX SULFOBUTYL ETHER SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | fosaprepitant dimeglumine | 70121-2631 |
| Steriscience Specialties Private Limited | fosaprepitant dimeglumine | 82449-231 |
| >Company | >Ingredient | >NDC |
fosaprepitant dimeglumine drug variants not containing BETADEX SULFOBUTYL ETHER SODIUM
Excipient focus: EDETATE DISODIUM
fosaprepitant dimeglumine drug variants containing EDETATE DISODIUM
fosaprepitant dimeglumine drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
fosaprepitant dimeglumine drug variants containing HYDROCHLORIC ACID
fosaprepitant dimeglumine drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | fosaprepitant dimeglumine | 70121-2631 |
| Steriscience Specialties Private Limited | fosaprepitant dimeglumine | 82449-231 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
fosaprepitant dimeglumine drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Athenex Pharmaceutical Division LLC | fosaprepitant dimeglumine | 70860-783 |
| Chia Tai Tianqing Pharmaceutical Group Co Ltd | fosaprepitant dimeglumine | 71731-5111 |
| Avenacy Inc | fosaprepitant dimeglumine | 83634-776 |
| >Company | >Ingredient | >NDC |
fosaprepitant dimeglumine drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: POLYSORBATE 80
fosaprepitant dimeglumine drug variants containing POLYSORBATE 80
fosaprepitant dimeglumine drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | fosaprepitant dimeglumine | 70121-2631 |
| Steriscience Specialties Private Limited | fosaprepitant dimeglumine | 82449-231 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
fosaprepitant dimeglumine drug variants containing SODIUM HYDROXIDE
fosaprepitant dimeglumine drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
fosaprepitant dimeglumine drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | fosaprepitant dimeglumine | 70121-2631 |
| Steriscience Specialties Private Limited | fosaprepitant dimeglumine | 82449-231 |
| >Company | >Ingredient | >NDC |
fosaprepitant dimeglumine drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
